Axon Enterprise, Inc $AXON Holdings Lifted by Maryland State Retirement & Pension System

Maryland State Retirement & Pension System increased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 8.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,626 shares of the biotechnology company’s stock after buying an additional 270 shares during the quarter. Maryland State Retirement & Pension System’s holdings in Axon Enterprise were worth $3,002,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Winthrop Advisory Group LLC purchased a new position in shares of Axon Enterprise during the second quarter valued at $315,000. Triasima Portfolio Management inc. grew its holdings in shares of Axon Enterprise by 4.3% during the second quarter. Triasima Portfolio Management inc. now owns 7,765 shares of the biotechnology company’s stock valued at $6,429,000 after buying an additional 317 shares in the last quarter. Louisiana State Employees Retirement System grew its holdings in shares of Axon Enterprise by 1.1% during the second quarter. Louisiana State Employees Retirement System now owns 9,600 shares of the biotechnology company’s stock valued at $7,948,000 after buying an additional 100 shares in the last quarter. First Financial Group Corp purchased a new position in shares of Axon Enterprise during the second quarter valued at $224,000. Finally, Shell Asset Management Co. grew its holdings in shares of Axon Enterprise by 28.7% during the second quarter. Shell Asset Management Co. now owns 2,480 shares of the biotechnology company’s stock valued at $2,053,000 after buying an additional 553 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $713.74, for a total value of $7,137,400.00. Following the completion of the sale, the chief executive officer owned 3,033,982 shares of the company’s stock, valued at $2,165,474,312.68. The trade was a 0.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Jennifer H. Mak sold 77 shares of the business’s stock in a transaction dated Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the completion of the sale, the chief accounting officer directly owned 15,003 shares of the company’s stock, valued at $11,402,280. This represents a 0.51% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 59,932 shares of company stock valued at $45,115,616. 4.40% of the stock is owned by corporate insiders.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $703.03 on Friday. Axon Enterprise, Inc has a fifty-two week low of $422.38 and a fifty-two week high of $885.91. The business has a 50-day moving average of $755.57 and a two-hundred day moving average of $712.63. The stock has a market capitalization of $55.19 billion, a P/E ratio of 173.59, a P/E/G ratio of 28.50 and a beta of 1.41. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company had revenue of $668.54 million during the quarter, compared to analysts’ expectations of $641.77 million. During the same quarter in the previous year, the firm earned $1.20 earnings per share. The business’s quarterly revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities research analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. JPMorgan Chase & Co. boosted their target price on Axon Enterprise from $730.00 to $850.00 and gave the company an “overweight” rating in a research note on Thursday, July 17th. Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the company an “overweight” rating in a research note on Friday, July 11th. Craig Hallum upgraded Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price on the stock in a research note on Tuesday, August 5th. Finally, UBS Group restated a “neutral” rating and issued a $840.00 target price (up previously from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Fourteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $841.64.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.